JPRN-UMIN000010067已完成未知
GLP-1 administration test for assessing the glucose metabolism and predictive efficacy of the incretin based treatment - GLP-1 administration test
Miyazaki university0 个研究点目标入组 50 人开始时间: 2013年4月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patient with severe complication (proliferative retinopathy, serum cleatinine > 2.0 mg/dL, cerebrovascular disease, and/or ischemic heart diseases), severe liver dysfunction and/or dementia.
研究者
相似试验
已完成
不适用
Verification of GLP-1 receptor agonist (Dulaglutide) additive effect on basal insulin therapy in patients with T2DMType2 diabetesJPRN-UMIN000024447Japan Red Cross Medical Center48
招募中
不适用
Is the GLP-1 response to an oral glucose load increased in South Asians as compared to Western-Europeans?gut peptide GLP-1sugar disease10018424NL-OMON40806eids Universitair Medisch Centrum20
已完成
2 期
Evaluation of the Glucoregulatory Effects of GLP-1 Receptor Activation in Patients with Type 2 Diabetes Mellitusinsulin secretion10018424DiabetesNL-OMON35750PRA International EDS12
招募中
不适用
Observation of using GLP-1 receptor agonist for wellness of brain activity in type 2 diabetes patients with mild cognitive impairmentJPRN-UMIN000030840Ogawa Red Cross Hospital50
已完成
Unknown
A test to assess blood glucose responses after intake of baked goods.Healthy humanJPRN-UMIN000049472iigata Bio-Research Park, Inc16